Quantum Genomics S.A.
QNNTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $20 | $2,515 | $5,800 |
| % Growth | -99.9% | -99.2% | -56.6% | – |
| Cost of Goods Sold | $1,145 | $1,439 | $29,502 | $20,344 |
| Gross Profit | -$1,145 | -$1,419 | -$26,987 | -$17,206 |
| % Margin | -11,453,070% | -7,169.6% | -1,073% | -296.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $16,709 |
| SG&A Expenses | $322 | $1,579 | $2,740 | $16,709 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $5 | $139 | $356 | -$13,802 |
| Operating Expenses | $328 | $1,718 | $3,096 | $2,907 |
| Operating Income | -$1,473 | -$3,137 | -$30,083 | -$17,093 |
| % Margin | -14,728,350% | -15,847.9% | -1,196.1% | -294.7% |
| Other Income/Exp. Net | -$7,420 | -$68 | $2,598 | -$96 |
| Pre-Tax Income | -$8,893 | -$3,205 | -$27,485 | -$17,189 |
| Tax Expense | $0 | -$34 | -$2,549 | $170 |
| Net Income | -$8,893 | -$3,171 | -$24,935 | -$17,359 |
| % Margin | -88,926,030% | -16,018.1% | -991.4% | -299.3% |
| EPS | -0.13 | -0.091 | -0.72 | -0.61 |
| % Growth | -42.9% | 87.4% | -18% | – |
| EPS Diluted | -0.13 | -0.091 | -0.72 | -0.61 |
| Weighted Avg Shares Out | 69,708 | 34,857 | 34,527 | 26,963 |
| Weighted Avg Shares Out Dil | 69,708 | 34,857 | 34,527 | 26,963 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $5 |
| Interest Expense | $11 | $21 | $18 | $13 |
| Depreciation & Amortization | $3 | $264 | $264 | $390 |
| EBITDA | -$1,470 | -$2,873 | -$29,819 | -$19,414 |
| % Margin | -14,702,370% | -14,515.5% | -1,185.6% | -334.7% |